The global gastric electrical stimulators market is estimated to be valued at USD 270.8 million in 2025 and is projected to reach USD 488.3 million by 2035, registering a compound annual growth rate ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The "Recognizing Obesity as a Disease" (ROAD) campaign, organized by the United Diabetes Forum in association with Harley Owners Group and supported by Novo Nordisk, aims to shift public perception of ...